- Home
- MNPR vs KVHI Comparison
MNPR vs KVHI Comparison
Compare MNPR & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- KVHI
- Stock Information
- Founded
- MNPR 2014
- KVHI 1978
- Country
- MNPR United States
- KVHI United States
- Employees
- MNPR N/A
- KVHI N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- KVHI Radio And Television Broadcasting And Communications Equipment
- Sector
- MNPR Health Care
- KVHI Technology
- Exchange
- MNPR Nasdaq
- KVHI Nasdaq
- Market Cap
- MNPR 95.5M
- KVHI 90.5M
- IPO Year
- MNPR 2019
- KVHI 1996
- Fundamental
- Price
- MNPR $18.09
- KVHI $5.11
- Analyst Decision
- MNPR Strong Buy
- KVHI
- Analyst Count
- MNPR 3
- KVHI 0
- Target Price
- MNPR $27.33
- KVHI N/A
- AVG Volume (30 Days)
- MNPR 1.5M
- KVHI 36.1K
- Earning Date
- MNPR 11-08-2024
- KVHI 11-07-2024
- Dividend Yield
- MNPR N/A
- KVHI N/A
- EPS Growth
- MNPR N/A
- KVHI N/A
- EPS
- MNPR N/A
- KVHI N/A
- Revenue
- MNPR N/A
- KVHI $118,366,000.00
- Revenue This Year
- MNPR N/A
- KVHI N/A
- Revenue Next Year
- MNPR N/A
- KVHI N/A
- P/E Ratio
- MNPR N/A
- KVHI N/A
- Revenue Growth
- MNPR N/A
- KVHI N/A
- 52 Week Low
- MNPR $1.37
- KVHI $4.17
- 52 Week High
- MNPR $38.50
- KVHI $5.49
- Technical
- Relative Strength Index (RSI)
- MNPR 60.19
- KVHI 67.80
- Support Level
- MNPR $16.26
- KVHI $4.35
- Resistance Level
- MNPR $19.70
- KVHI $4.65
- Average True Range (ATR)
- MNPR 2.15
- KVHI 0.20
- MACD
- MNPR -0.07
- KVHI 0.05
- Stochastic Oscillator
- MNPR 74.36
- KVHI 86.36
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About KVHI KVH Industries Inc.
KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.